harvard Infectious Diseases in Adults 2025

“2025 ACP Internal Medicine Board Review Course – Greater Chicago, IL” has been added to your cart. View cart

harvard Infectious Diseases in Adults 2025

Rated 4.6 out of 5 based on 23 customer ratings

(23 customer reviews)

Original price was: $1,375.97.Current price is: $179.97.

Frequently bought together:

Harvard Pulmonary and Critical Care Medicine 2025

Harvard Pulmonary and Critical Care Medicine (2023, 2024, 2025)

Harvard Female Sexual Wellness Identifying Concerns and Treatment Options 2025

Dermatology ANNUAL MEETING ON-DEMAND (2024, 2025)

Firestein & Kelley's Textbook of Rheumatology - E-Book 12th Edition

Harvard GI Motility & Brain-Gut Disorders Evidence vs Consensus 2024

Total: $1,009.82

Instant Access: Start Learning Now!

Immediate access to your resources, enabling you to start your learning journey without delay.

Affordable Pricing

At ChidoPhysio, we guarantee affordability. Our prices are always up to 80% lower than other providers, ensuring you receive top-quality Physical therapy books without breaking the bank.

Dedicated Customer Support at Your Service

At ChidoPhysio, our dedicated customer support team is here to assist you every step of the way 24/7 . Your questions and concerns are our top priority.

Payment Secure and Encrypted with PayPal and Stripe

Rest easy knowing that your payment is secure and encrypted when you choose to purchase our dental education resources. We offer trusted payment options, including PayPal and Stripe, to safeguard your financial information. Your privacy and security are our top priorities.

Description
Reviews (23)

Description

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases

Infectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions.

OVERVIEW

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:
- Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases
- Newer antimicrobials and treatment strategies for highly resistant infections
- Prevention and treatment of infections in immunocompromised hosts
- Update on antifungal diagnostics and therapy
- State-of-the-art and multidisciplinary approaches to common infections
- Clinical approaches to complex, rare, and “don’t-miss” infections
- New, evolving, emerging, and re-emerging infectious diseases
- Infections in persons with substance use disorder
- What’s new in HIV prevention and management
- The latest on COVID-19, including long COVID
As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Highlights of the 2025 Program

Expanded Case-Based and Problem-Solving Education

The 2025 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops. Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:
- MRSA and VISA (vancomycin-intermediate Staph aureus)
- Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
- Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
- Vancomycin-resistant enterococci (VRE)
- Aspergillus and non-aspergillus mold infections
- Candida auris
- Nontuberculous mycobacteria (NTM)
Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:
- Respiratory viral infections, including COVID-19
- New and updated vaccines
- Infections in the expanding populations of immunocompromised hosts
- Infections in persons with substance use disorder
- Infections of travelers and foreign-born persons
- Systemic fungal infections
- Native and device-related orthopedic infections
- Central nervous system (CNS) infections
- Ear, nose, and throat (ENT) and eye infections
- Skin and soft tissue infections
- Bronchiectasis and pneumonia
- HIV and its infectious and noninfectious complications
- PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
- Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
- Hepatitis B and C infections
- Tick- and mosquito-borne infections
- Clostridioides difficile infection
- Complicated urinary tract infections
- Intra-abdominal infections
Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:
- Rare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus
- Re-emergence of vaccine-preventable diseases, including poliomyelitis
- Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
- Global infectious diseases of clinical importance
Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:
- Selecting the best antimicrobial and duration of treatment
- Rapid detection and empiric treatment of life-threatening infectious diseases
- Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
- Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop
Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:
- Antimicrobial stewardship to prevent resistance and reduce cost
- Infection control to reduce transmission in health care settings
- Early inpatient ID consultations to improve outcomes
- Strategies for management of infection in persons who inject drugs (PWID)
Optimized for Remote Education

The 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.

Schedule

Print

Monday, April 28, 2025

Session 1: Monday Morning

8:00am to 8:15am

Introduction and Road Map: Infectious Diseases of Adults

Dr. Nesli Basgoz

8:15am to 9:00am

Principles of Antimicrobial Therapy

Dr. Alyssa R. Letourneau

9:00am to 9:45am

Update on Antifungal Diagnostics and Therapy

Dr. Michael K. Mansour

9:45am to 9:55am

Break

9:55am to 10:40am

Antimicrobial Stewardship

Dr. Alyssa R. Letourneau

10:40am to 11:10am

An Antibiotic Allergy Toolkit

Dr. Kimberly Blumenthal

11:10am to 11:45am

Infection Control 101 for the ID Clinician

Dr. Erica Shenoy

11:45am to 12:15pm

Live Q & A

12:15pm to 1:15pm

Break

Session 2: Monday Afternoon

1:15pm to 1:55pm

Panel Workshop #1: Resistant Gram-Positive Infections

Moderator: Dr. Alyssa R. Letourneau
Drs. Roby P. Bhattacharyya, Ramy H. Elshaboury, and Cecilia Li

1:55pm to 2:35pm

Panel Workshop #2: Resistant Gram-Negative Infections

Moderator: Dr. Alyssa R. Letourneau
Drs. Roby P. Bhattacharyya, Ramy H. Elshaboury, and Cecilia Li

2:35pm to 3:05pm

Live Q & A

3:05pm to 3:15pm

Break

3:15pm to 4:00pm

Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches

Dr. Elizabeth Hohmann

4:00pm to 4:40pm

Live: Plenary: Highly Pathogenic Avian Influenza

Dr. Timothy Uyeki

Note: This lecture will not be recorded

4:40pm to 5:00pm

Live Q & A

5:00pm to 5:30pm

Skin and Soft Tissue Infections

Dr. Sandra B. Nelson

5:30pm to 5:45pm

Live Q & A

Tuesday, April 29, 2025

Session 3: Tuesday Morning

8:00am to 9:00am

Encephalitis and Meningitis: The Newest Guidelines and Best Practices

Dr. Allan R. Tunkel

9:00am to 9:50am

Tick Talk: Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections

Dr. Kimon C. Zachary

9:50am to 10:00am

Break

10:00am to 10:50am

Bone and Joint Infections: A Conceptual Framework

Dr. Sandra B. Nelson

10:50am to 11:40am

Staphylococcus aureus: Déjà Vu All Over Again

Dr. Henry F. Chambers

11:40am to 12:10pm

Live Q & A

12:10pm to 1:10pm

Break

Session 4: Tuesday Afternoon

1:10pm to 1:45pm

Panel Workshop #3: Native Bone Infections

Moderator: Dr. Sandra B. Nelson
Drs. Barbra M. Blair, Jeremy Goverman, and J. Frank Simeone

1:45pm to 2:20pm

Panel Workshop #4: Orthopedic Device Infections: Prosthetic Joint Infections

Moderator: Dr. Sandra B. Nelson
Drs. Barbra M. Blair, Hayden N. Box, and J. Frank Simeone

2:20pm to 2:50pm

Live Q & A

2:50pm to 3:00pm

Break

3:00pm to 3:50pm

State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections

Dr. Kevin L. Ard

3:50pm to 4:40pm

New and Emerging Viruses

Dr. Martin S. Hirsch

4:40pm to 5:00pm

Live Q & A

5:00pm to 5:45pm

Live: Keynote Lecture—Protecting Public Health with Vaccines: Understanding Our Past, Protecting Our Future

Dr. Paul Offit

CME credit not offered for this session

5:45pm to 6:00pm

Live Q & A

Wednesday, April 30, 2025

Session 5: Wednesday Morning

8:00am to 8:40am

Panel Workshop #5: Multidisciplinary Management of Intra-abdominal Infections (Including New Guidelines)

Moderator: Dr. Nesli Basgoz
Drs. Peter J. Fagenholz and Ashraf Thabet

8:40am to 9:20am

Critical Care ID

Dr. Lisa Bebell

9:20am to 9:50am

Live Q & A

9:50am to 10:00am

Break

10:00am to 10:55am

Endocarditis and Cardiac Device Infections

Dr. Molly L. Paras

10:55am to 11:40am

The Syndemic of SUD and Infection: Updated Approaches for 2025

Dr. Jennifer A. Johnson

11:40am to 12:10pm

Live Q & A

12:10pm to 1:10pm

Break

Session 6: Wednesday Afternoon

1:10pm to 1:45pm

Panel Workshop #6: Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder)

Moderator: Dr. Molly Paras
Drs. Arminder S. Jassar, Wei Sum Li, and Evin Yucel

1:45pm to 2:20pm

Panel Workshop #7: Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder)

Moderator: Dr. Molly Paras
Drs. Arminder S. Jassar, Wei Sum Li, and Evin Yucel

2:20pm to 2:50pm

Live Q & A

2:50pm to 3:00pm

Break

3:00pm to 3:40pm

Panel Workshop #8: Multidisciplinary Management of Complex Urinary Tract Infections

Moderator: Dr. Jacob Lazarus
Dr. Kristin J. Hung

3:40pm to 4:30pm

Advances in Viral Hepatitis: HBV and HCV

Dr. Arthur Y. Kim

4:30pm to 5:00pm

Live Q & A

Thursday, May 1, 2025

Session 7: Thursday Morning

8:00am to 8:45am

Cellular and Immune-Based Therapies for Cancer 2025: What the ID Clinician Needs to Know

Dr. Michael K. Mansour

8:45am to 9:40am

Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy

Dr. Camille Nelson Kotton

9:40am to 9:50am

Break

9:50am to 10:45am

Infections in Hematologic Malignancies and Stem Cell Transplantation

Dr. Sarah Hammond

10:45am to 11:30am

Flummoxing Cases in Fungal Infections

Drs. Michael K. Mansour and Sarah Turbett

11:30am to 12:00pm

Live Q & A

12:00pm to 1:00pm

Break

Session 8: Thursday Afternoon

1:00pm to 1:45pm

Updates on COVID-19, Including Long COVID-19

Dr. Rajesh T. Gandhi

1:45pm to 2:15pm

Navigating New Vaccines: Updates and Recommendations

Dr. Camille Nelson Kotton

2:15pm to 2:45pm

Live Q & A

2:45pm to 2:55pm

Break

2:55pm to 3:35pm

Pre- and Post-Exposure Prophylaxis for HIV and STIs

Dr. Kevin L. Ard

3:35pm to 4:20pm

What’s New in the Care of People with HIV in 2025

Dr. Rajesh T. Gandhi

4:20pm to 5:05pm

Understanding and Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections

Dr. Nesli Basgoz

5:05pm to 5:30pm

Live Q & A

Friday, May 2, 2025

Session 9: Friday Morning

8:00am to 8:50am

Tuberculosis Update

Dr. Rocío Hurtado

8:50am to 9:40am

Bronchiectasis, Pneumonia, and NTM Infections: Anatomic and Clinical Approaches

Dr. Nesli Basgoz

9:40am to 9:50am

Break

9:50am to 10:20am

The Latest on Major Respiratory Viral Infections

Dr. Michael Ison

10:20am to 11:10am

Eye and ENT Infections: What You Need to Know in 2025

Dr. Miriam B. Barshak

11:10am to 11:40am

Live Q & A

11:40am to 12:40pm

Break

Session 10: Friday Afternoon

12:40pm to 1:40pm

Live: New England Journal of Medicine Clinicopathologic Conference (CPC)

Drs. George A. Alba, Melis N. Anahtar, Mark A. Anderson, David M. Dudzinski, Angela G. Fowler, Christina Shincovich, James R. Stone, and Stephen Threlkeld

Note: This event will not be recorded

1:40pm to 1:55pm

Live Q&A

1:55pm to 2:30pm

Tropical Medicine: 2025 Review and Update

Dr. Edward T. Ryan

2:30pm to 3:10pm

Cases in Global Infectious Diseases

Dr. Edward T. Ryan

3:10pm to 3:25pm

Live Q & A

3:25pm to 3:35pm

Break

3:35pm to 4:10pm

Panel Workshop #9: Management of Complex Nontuberculous Mycobacterial (NTM) Infection: Pulmonary

Moderator: Dr. Rocío Hurtado
Drs. Michael Lanuti, Ruvandhi Nathavitharana, and Christopher J. Richards

4:10pm to 4:45pm

Panel Workshop #10: Management of Complex Nontuberculous Mycobacterial (NTM) Infection: Extrapulmonary

Moderator: Dr. Rocío Hurtado
Drs. Kristen M. Hysell, Alyssa R. Letourneau, and Alex E. Rock

4:45pm to 5:15pm

Live Q & A

23 reviews for harvard Infectious Diseases in Adults 2025

Alex Turner, Health Tech Entrepreneur, Seattle, WA

Rated 4 out of 5

"Reviewing this course is essential for developing digital health tools for antimicrobial stewardship and diagnostic support. It provides a clear pict...More
"Reviewing this course is essential for developing digital health tools for antimicrobial stewardship and diagnostic support. It provides a clear picture of clinical decision points and data interpretation challenges faced by clinicians."

Helpful? 0 0

Dr. Patricia Wallace, Nephrologist, Missoula, MT

Rated 4 out of 5

"Highly relevant for managing infections in ESRD and transplant patients. The 2025 guidance on dosing antibiotics in renal impairment and managing vir...More
"Highly relevant for managing infections in ESRD and transplant patients. The 2025 guidance on dosing antibiotics in renal impairment and managing viral infections post-transplant greatly enhances collaboration with our ID colleagues."

Helpful? 0 0

Maya Reddy, Pre-Med Student, Berkeley, CA

Rated 4 out of 5

"An incredible, in-depth look at a dynamic field of medicine. The 2025 lectures on pandemic response and emerging viruses are particularly fascinating...More
"An incredible, in-depth look at a dynamic field of medicine. The 2025 lectures on pandemic response and emerging viruses are particularly fascinating. It has profoundly increased my appreciation for global health."

Helpful? 0 0

Dr. Evan Pierce, Rural Internal Medicine, Rochester, MN

Rated 4 out of 5

"This course is a critical resource for managing complex infections without immediate ID specialist access. The 2025 diagnostic and treatment guidelin...More
"This course is a critical resource for managing complex infections without immediate ID specialist access. The 2025 diagnostic and treatment guidelines for endocarditis and CNS infections are a lifeline for my practice."

Helpful? 0 0

Dr. Kenji Tanaka, Internist, Honolulu, HI

Rated 4 out of 5

"The Harvard faculty delivers a complex and global topic with unmatched clarity. This format is an excellent way for physicians everywhere to ensure t...More
"The Harvard faculty delivers a complex and global topic with unmatched clarity. This format is an excellent way for physicians everywhere to ensure their knowledge of tropical and travel medicine is current with the latest evidence."

Helpful? 0 0

Caleb Ortiz, Medical Science Liaison, Vaccines, San Francisco, CA

Rated 4 out of 5

"This course provides the deep clinical background on the burden of vaccine-preventable diseases in adults I need for meaningful scientific exchange. ...More
"This course provides the deep clinical background on the burden of vaccine-preventable diseases in adults I need for meaningful scientific exchange. The 2025 data on new vaccine platforms and recommendations is perfectly presented."

Helpful? 0 0

Dr. Thomas Reed, Retired ID Physician, Sarasota, FL

Rated 4 out of 5

"A fantastic way to stay current on the remarkable advances in my field. The evolution of diagnostics and therapeutics, especially for resistant Gram-...More
"A fantastic way to stay current on the remarkable advances in my field. The evolution of diagnostics and therapeutics, especially for resistant Gram-negative infections, is breathtaking. The Harvard faculty remains the gold standard in education."

Helpful? 0 0

Anika Sharma, Clinical Researcher, Antibiotic Development, Washington, D.C.

Rated 4 out of 5

"An excellent, unbiased overview of the current treatment landscape and unmet needs in bacterial infections. This is invaluable for understanding the ...More
"An excellent, unbiased overview of the current treatment landscape and unmet needs in bacterial infections. This is invaluable for understanding the clinical context and endpoints that matter most when designing new antibiotic trials."

Helpful? 0 0

Dr. Neil Gupta, Gastroenterologist, Dallas, TX

Rated 4 out of 5

"A fascinating and important cross-disciplinary update. The 2025 lectures on managing C. diff recurrence with new agents and the GI manifestations of ...More
"A fascinating and important cross-disciplinary update. The 2025 lectures on managing C. diff recurrence with new agents and the GI manifestations of systemic infections (e.g., CMV colitis) provide essential knowledge for my practice."

Helpful? 0 0

Dr. Mark Williams, Internal Medicine, Miami, FL

Rated 4 out of 5

"Extremely practical and directly applicable to my practice. The 2025 treatment algorithms for recurrent UTIs, cellulitis, and community-acquired pneu...More
"Extremely practical and directly applicable to my practice. The 2025 treatment algorithms for recurrent UTIs, cellulitis, and community-acquired pneumonia are clear, concise, and designed for efficiency without sacrificing quality of care."

Helpful? 0 0

Dr. Irene Kostas, Oncologist, Cleveland, OH

Rated 5 out of 5

"Crucial for any oncologist. The 2025 management of immune-related adverse events from checkpoint inhibitors (like colitis and hepatitis) and infectio...More
"Crucial for any oncologist. The 2025 management of immune-related adverse events from checkpoint inhibitors (like colitis and hepatitis) and infections in patients on CAR-T therapy is an rapidly evolving and essential part of cancer care."

Helpful? 0 0

Chloe Davies, Medical Student (Infectious Disease Interest), Hanover, NH

Rated 5 out of 5

"This course solidified my decision to pursue ID. It makes complex topics like interpreting interferon-gamma release assays and the mechanism of novel...More
"This course solidified my decision to pursue ID. It makes complex topics like interpreting interferon-gamma release assays and the mechanism of novel antivirals not only understandable but fascinating. The best supplemental education I've had."

Helpful? 0 0

Dr. Aaron Wilcox, Emergency Medicine, Philadelphia, PA

Rated 5 out of 5

"Highly relevant for the ED. The 2025 protocols for managing febrile neutropenia, acute bacterial meningitis, and necrotizing soft tissue infections a...More
"Highly relevant for the ED. The 2025 protocols for managing febrile neutropenia, acute bacterial meningitis, and necrotizing soft tissue infections are presented with a clear, actionable focus that is essential for emergency stabilization."

Helpful? 0 0

Jonathan Reid, Public Health Officer, Portland, OR

Rated 5 out of 5

"This course provides the deep clinical background I need for public health decision-making. The 2025 perspectives on emerging zoonotic threats, pande...More
"This course provides the deep clinical background I need for public health decision-making. The 2025 perspectives on emerging zoonotic threats, pandemic preparedness, and community-based MRSA are invaluable for outbreak response and policy."

Helpful? 0 0

Dr. Maria Flores, Travel Medicine Specialist, Houston, TX

Rated 5 out of 5

"An excellent and timely update. The 2025 reviews of emerging geographic hotspots for malaria, dengue, and antibiotic-resistant enteric infections, al...More
"An excellent and timely update. The 2025 reviews of emerging geographic hotspots for malaria, dengue, and antibiotic-resistant enteric infections, alongside updated vaccination strategies, are critical for preparing travelers safely."

Helpful? 0 0

David Chen, PharmD, BCIDP, Antimicrobial Stewardship, Phoenix, AZ

Rated 5 out of 5

"The pharmacotherapy content is state-of-the-art. The 2025 nuanced discussions on new antibiotics, PK/PD optimization in obesity and renal failure, an...More
"The pharmacotherapy content is state-of-the-art. The 2025 nuanced discussions on new antibiotics, PK/PD optimization in obesity and renal failure, and managing adverse drug reactions provide the depth I need for stewardship protocols."

Helpful? 0 0

Dr. Robert Yi, Pulmonologist/Critical Care, New York, NY

Rated 5 out of 5

"Essential for the ICU. The 2025 sessions on nosocomial pneumonia (HAP/VAP), managing difficult-to-treat resistance, and advanced approaches to source...More
"Essential for the ICU. The 2025 sessions on nosocomial pneumonia (HAP/VAP), managing difficult-to-treat resistance, and advanced approaches to source control are presented with a focus on critical care that is absolutely vital."

Helpful? 0 0

Amara Johnson, NP, Immunocompromised Host Service, Atlanta, GA

Rated 5 out of 5

"As an NP, this course provides the nuanced understanding I need to manage our most vulnerable patients. The 2025 updates on pre-emptive versus prophy...More
"As an NP, this course provides the nuanced understanding I need to manage our most vulnerable patients. The 2025 updates on pre-emptive versus prophylactic strategies for viruses like CMV and BK are directly applicable and incredibly helpful."

Helpful? 0 0

Dr. Samuel Cohen, Immunologist, Denver, CO

Rated 5 out of 5

"A masterclass in infections in the immunocompromised host. The 2025 deep dives on managing infections in patients on biologics, post-transplant, and ...More
"A masterclass in infections in the immunocompromised host. The 2025 deep dives on managing infections in patients on biologics, post-transplant, and with inherited immunodeficiencies are presented with exceptional depth and clarity. Invaluable."

Helpful? 0 0

Priya Sharma, MD, Hospitalist, Chicago, IL

Rated 5 out of 5

"This course empowers the front-line clinician to manage complex infections confidently. The 2025 algorithms for sepsis and septic shock, incorporatin...More
"This course empowers the front-line clinician to manage complex infections confidently. The 2025 algorithms for sepsis and septic shock, incorporating the latest resuscitation and antibiotic timing evidence, are practice-changing for my daily work."

Helpful? 0 0

Dr. Ben Carter, Internal Medicine Resident, Baltimore, MD

Rated 5 out of 5

"The ultimate resource for antimicrobial stewardship on the wards. The lectures on parsing MRSA, VRE, and C. diff protocols, along with guidance on wh...More
"The ultimate resource for antimicrobial stewardship on the wards. The lectures on parsing MRSA, VRE, and C. diff protocols, along with guidance on when to consult ID, have dramatically improved my confidence and patient care. Essential for board prep."

Helpful? 0 0

Marcus Thorne, Infection Preventionist, RN, MPH, Los Angeles, CA

Rated 5 out of 5

"This course is a cornerstone of our hospital's infection control strategy. The 2025 updates on outbreak management in healthcare settings and prevent...More
"This course is a cornerstone of our hospital's infection control strategy. The 2025 updates on outbreak management in healthcare settings and preventing transmissions of multi-drug resistant organisms are presented with unparalleled clarity and immediate practicality."

Helpful? 0 0

Dr. Eleanor Vance, Infectious Disease Specialist, Boston, MA

Rated 5 out of 5

"An exceptional and critical update. The 2025 sessions on managing complex antimicrobial resistance (especially novel beta-lactamase inhibitors) and e...More
"An exceptional and critical update. The 2025 sessions on managing complex antimicrobial resistance (especially novel beta-lactamase inhibitors) and emerging fungal pathogens were worth the entire course. The diagnostic algorithms are invaluable."

Helpful? 0 0

Add a review